India looking toward continuous manufacturing; DuPont buys Dyadic's industrial enzyme biz;

> The Indian engineering and pharma alliance STEER has created a startup to help the Indian industry move to continuous manufacturing. Report

> Florida-based protein developer Dyadic International intends to sell its industrial technology business to DuPont ($DD) for $75 million to concentrate on its pharmaceutical business. Release (PDF)

> C.O. Truxton of Bellmawr, NJ, is recalling one lot of codycycle hyalite tablets manufactured in Puerto Rico by Blu Caribe because the bar code on the bottles incorrectly scans as phenobarbital tablets. Notice

> Florida-based Quest Manufacturing is looking for OTC makers to buy to build its business. Release

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

After months of delay for ultra-pricey gene therapy Zynteglo, Bluebird Bio is hoping to dose its first German patients in the first half of the year.

North Carolina is providing some financial assistance for the construction of Audentes gene therapy facility in Sanford, North Carolina. (Astellas)